Status:
COMPLETED
Noninvasive Brain Stimulation on Memory in Individuals With Mild Cognitive Impairment and History of Brain Injury
Lead Sponsor:
University of Texas Southwestern Medical Center
Collaborating Sponsors:
U.S. Army Medical Research and Development Command
Conditions:
Amnestic Mild Cognitive Impairment
Traumatic Brain Injury
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
The study will examine the efficacy of high definition transcranial direct current stimulation (HD-tDCS) and its influence on episodic memory in patients with amnestic mild cognitive impairment and a ...
Eligibility Criteria
Inclusion
- Age 50 and older
- Native English speakers
- 12 years of education or higher
- Active diagnosis of aMCI
- History of TBI based on VA/DOD criteria
Exclusion
- TBI within the past 2 years
- Lifetime history of stroke, transient ischemic attack, heart attack, or congestive heart failure
- Lifetime history of epilepsy
- Major psychiatric disorders (i.e., posttraumatic stress disorder, bipolar disorder, schizophrenia)
- Substance use disorder
- Has metal fragments in head
- Taking medications that may interact with the HD-tDCS effect (i.e., amphetamines, L-dopa, carbamazepine, sulpiride, pergolide, lorazepam, dextromethorphan, D-cycloserine, flunarizine, or ropinirole)
Key Trial Info
Start Date :
December 5 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2025
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT04504630
Start Date
December 5 2020
End Date
January 30 2025
Last Update
May 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Southwestern Medical Center
Dallas, Texas, United States, 75390